Stay updated with breaking news from Partial Agonists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced results from a pharmacodynamic study demonstrating that OPVEE® rapidly reverses opioid-induced...
This head-to-head pharmacodynamic study in healthy volunteers examined the ability of both OPVEE and intranasal naloxone to reverse opioid-induced respiratory depression, which is the shallow and slow breathing associated with an opioid overdose In this model, OPVEE 2.7mg reversed respiratory depression to 95% of pre-opioid baseline within 5 minutes; a similar reversal following a 4 […]
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that the U.S. Food and Drug Administration (FDA) approved OPVEE® (nalmefene) nasal spray for the...
/PRNewswire/ -- Sandoz, a global leader in generic and biosimilar medicines, today announced the US launch of its authorized generic of Narcan® (naloxone...
/PRNewswire/ -- Sandoz, a global leader in generic and biosimilar medicines, today announced the US launch of its authorized generic of Narcan® (naloxone...